Loading news...
iHuman Inc. Sponsored ADR (NYSE: IH - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 3,198 shares, a growth of 395.8% from the December 15th total of 645 shares. Based on an average daily volume of 5,705
BEIJING , Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.
iHuman (IH) offers educational apps and devices, trading at a deep discount to global peers and below its cash value, signaling undervaluation. IH is expanding internationally, notably in the US through a partnership with Cricket Media, diversifying away from China policy risks. Despite revenue declines, IH achieved strong net income growth in 2Q25 due to significant cost reductions, and maintains a highly liquid balance sheet.
Beijing, China--(Newsfile Corp. - November 24, 2025) - iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor Relations Director, Justin Zhang, will present at NobleCon21 - Noble Capital Markets' 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL., on Wednesday, December 3rd at 12:00 PM Eastern Standard Time.
BEIJING , Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025.
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va.
BEIJING , June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.
BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/.
BEIJING , March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.
BEIJING , Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.
BEIJING , Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024.
BEIJING , June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.
BEIJING , April 25, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/.
BEIJING , Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.
BEIJING , Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today published its first environmental, social and governance (ESG) report, covering its ESG activities in 2022. The report provides comprehensive information on the Company's ESG governance mechanisms and details its performance across a range of environmental and social indicators.
BEIJING , Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Revenues were RMB261.5 million (US$35.8 million), compared with RMB251.5 million in the same period last year.
BEIJING , Sept. 21, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2023.
BEIJING , Aug. 4, 2023 /PRNewswire/ -- Ms. Vivien Wang, Director and Chief Financial Officer (CFO) of iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, was recognized as "CFO of the Year 2022-2023" in the 2022-2023 Financial Performance Awards (the "Awards") presented by North American Business.
While acquiring little-known stocks can be a scary proposition, you should also realize that going with the predictable also has its risks. Fundamentally, anytime you enter the capital markets, you're taking risks.
iHuman Inc (NYSE: IH) reported second-quarter FY21 revenue growth of 105.9% year-on-year, to RMB221.3 million ($34.3 million). Revenues from online subscriptions rose 110.1% Y/Y to RMB199.2 million ($30.9 million).